David Cicilline

I demand a recorded vote. The Acting CHAIR. Pursuant to clause 6 of rule XVIII, further proceedings on the amendment offered by the gentleman from Rhode Island will be postponed. Amendment No. 10 Offered by Mr. Pocan The Acting CHAIR. It…

I rise as the designee of the gentlewoman from Texas (Ms. Jackson Lee) to offer an amendment. The Acting CHAIR. The Clerk will designate the amendment. The text of the amendment is as follows: Page 29, line 21, insert after ``Code'' the…

I have an amendment at the desk. The Acting CHAIR. The Clerk will designate the amendment. The text of the amendment is as follows: Page 29, line 21, insert after ``Code'' the following: ``, except for a special rule''. Page 29, insert…

We have to do everything that we can and use all of the tools available to us to keep the pressure on and really took to confront the IRGC and Iran.

I believe that all of us assembled here, both those of us on the Committee and our assembled panel of witnesses, recognize that technology often evolves much faster than the law.

And we talk a lot about another effort to permit the Federal Government to negotiate discounted prices directly with pharmaceutical companies to the Medicare program, which they're prohibited from doing.

The ability to at least have some bargaining power against these pharmaceutical companies in the marketplace is something that we should attempt to preserve as much as we can.

Mr. Balto argues in his written testimony that there is an 'increasing disregard of the antitrust laws in the pharmaceutical area' and argues as a result that 'consumers suffer from a lack of choice in the marketplace.'

So some consumer groups have argued that PBMs keep the proceeds of rebates and discounts and keep a disproportionate share of that for themselves.

And Mr. Balto also argued that PBMs exclusivity arrangements with some drug manufacturers can keep drug prices artificially high by keeping lower-price drugs off the market and by incentivizing PBMs through manufacturer rebates to switch…

And so is it fair to conclude that your assessment is that the transparency related to your relationship with the pharmaceutical company, that it could produce higher costs for the consumer?

I particularly want to acknowledge the extraordinary corporate citizenship of CVS, a company that I have admired for a long time.

Are there legislative efforts we can undertake to increase compliance by State and local governments?

So under current law and practice no notice is provided to local law enforcement or to the U.S. Attorney's Office in that jurisdiction. Is that correct?

But you agree, do you not, Madam Attorney General, that if the law in fact said the background check has to be completed and the transfer approved we would reduce the likelihood that people who are ineligible, 16,000 in that 4-year period…

Thank you, Madam Attorney General, for being here, particularly at a moment when I know you and the entire Justice Department is offering full assistance to your counterparts in France to respond to this horrific terrorist attack.

I'll continue to push for sensible gun safety measures like preventing suspects on our terrorist watchlist from buying guns.

I reject the assertion that there's no room for improvement. Clearly, there is.

I would ask the Chairman, consistent with his views that there are some problems with existing law, that we work together to allocate the funds so that all of the information gets to the National Instant Criminal Background Check System.

Even the ATF has said that this very vague standard frustrates prosecutions.

I would just ask the gentleman if he would commit to working with Congresswoman Hahn and I and a group of others that are really interested in restoring and modernizing the Highway Beautification Act so that we might work collaboratively…

Finally, the President, obviously, has just announced 50 Special Forces will be dispatched to Syria to advise and assist Kurdish forces in that region.

I remain very concerned that the absence of a coherent strategy for success in Syria and Iraq to defeat ISIL...

Thank you, Mr. Chairman, for your legislation that created the TIP Report in your early years upon this issue.

The question is, will America lead? And that's what I'd like to have in the days and months to come.